Form 4: Organon & Co. Corporate Controller Kathryn DiMarco Reports Acquisition of Restricted Stock Units

Kathryn DiMarco, Corporate Controller of Organon & Co., reports the acquisition of 31,914 restricted stock units (RSUs) that will vest in three equal installments.

Summary

• Kathryn DiMarco, Corporate Controller of Organon & Co., filed a Form 4 to report changes in beneficial ownership.
• On March 29, 2024, DiMarco was granted 31,914 restricted stock units (RSUs).
• Each RSU represents a contingent right to receive one share of Organon common stock.
• The RSUs will vest and be distributed as shares of Organon common stock in three equal installments on March 29, 2025, March 29, 2026, and March 29, 2027.
• Following the transaction, DiMarco directly owns 31,914 derivative securities.

Sentiment

Score: 6

Explanation: The sentiment is neutral as the document simply reports a routine transaction. The grant of RSUs can be seen as a positive sign of aligning management interests with shareholders, but it's not a major event.

Positives

• The grant of RSUs to a key officer like the Corporate Controller suggests an alignment of interests with the company's long-term performance.

Future Outlook

The document does not contain any specific forward-looking statements regarding the company's financial performance or future prospects, focusing solely on the reporting of a transaction involving restricted stock units.

Industry Context

Form 4 filings are routine disclosures required by the SEC to ensure transparency in insider trading. The granting of RSUs is a common practice to incentivize and retain key employees in publicly traded companies, aligning their interests with those of shareholders.

Stakeholder Impact

• The grant of RSUs aligns the interests of the Corporate Controller with those of the shareholders, incentivizing her to contribute to the company's long-term success.

Key Dates